Enhancing Diagnostic Accuracy: How Pristina Recon DL Transforms Digital Breast Tomosynthesis for Radiologists
Dr. Inês Pereira, a breast radiologist with over two decades of experience based in Santarem, Portugal, manages a dedicated unit serving a population of 200,000. Her practice has evolved from standard digital mammography to advanced Digital Breast Tomosynthesis (DBT) in 2012, subsequently integrating Contrast-Enhanced Spectral Mammography (CSM) and MRI. For Dr. Pereira, AI is not a replacement for clinical judgment but a critical augmentation tool, particularly when navigating the challenges of dense breast tissue.
Leveraging Deep Learning to Improve Lesion Conspicuity, Reduce Artifacts, and Streamline Workflow in Dense Breasts
The integration of deep learning into image reconstruction has fundamentally altered DBT capabilities through the introduction of Pristina Recon DL. This sophisticated post-processing algorithm generates significantly sharper, more homogeneous images compared to traditional reconstructions that often suffer from noise or geometric distortions. The technology excels at enhancing the visibility of soft tissue mass lesions, especially on 2D synthetic images where lesions frequently mask against background structures. By improving lesion conspicuity without altering underlying anatomical data, it provides a decisive advantage in difficult diagnostic scenarios.
Beyond Clarity: Mitigating Artifacts and Ensuring Volumetric Consistency
The practical impact of this technology extends well beyond simple image clarity. The algorithm effectively mitigates artifacts that previously hindered accurate diagnosis. Replication artifacts associated with dense objects, such as surgical clips from prior biopsies, are drastically reduced, allowing for precise characterization of micro-calcifications. Furthermore, movement artifacts caused by patient breathing or minor shifts during acquisition are minimized. This ensures that the entire breast volume remains consistent when scrolling through slices, a stability crucial for accurately assessing margins and distinguishing between suspicious and benign findings.
Dr. Pereira notes that the elimination of the "shrinking effect" observed in earlier DBT versions represents a major workflow improvement. Radiologists can now scroll through volumetric datasets without the breast appearing to change size, facilitating a more intuitive review process. Additionally, the reduction in skin and nipple artifacts streamlines the evaluation of axillary and intramammary lymph nodes. By reducing recall rates and improving the detection of invasive cancers early in their course, these advanced reconstruction algorithms align perfectly with the primary goal of breast imaging: early and accurate diagnosis.
Ultimately, the adoption of Pristina Recon DL empowers radiologists to make more confident diagnoses, reducing diagnostic uncertainty and optimizing patient outcomes. As the field continues to evolve, tools that enhance image quality while preserving the radiologist's clinical judgment remain essential for the future of precision breast cancer care.
